Patent · US Expired

Antibody to stem cell factor

US7285640B2 · kind B2 · utility

6Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2002
Grant dateOct 23, 2007
Priority date
Expiry dateOct 8, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides human antibodies specific for stem cell factor that contain at least one CDR derived from a combinatorial antibody library. The invention also provides pharmaceutical compositions comprising the antibodies and methods of treating asthma. The invention further provides methods of detecting stem cell factor using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.